Rebane et al.106further demonstrated elevated miR-146a levels in chronic AD lesions and identified novel targets, including CCL5 and caspase recruitment domain-containing protein 10, which mediate the degradation of nuclear factor kappa-B (NF-κB) inhibitors. This evidence concerns the gene NFKB1 and Alzheimer disease.